IQVIA_Rules_Based_Medicine_Logo - rgb

(+01) 512 835 8026

Email us

Type your search term and press "enter."

Angiotensin-Converting Enzyme

Angiotensin-Converting Enzyme

Angiotensin-Converting Enzyme (ACE) is a member of the angiotensin family which includes peptides that act as vasoconstricting agents. ACE converts angiotensin to its activated form (called angiotensin II). ACE is also involved in the inactivation of bradykinin, a potent vasodilator. These two actions make ACE an ideal target in the treatment of conditions such as high blood pressure, heart failure, diabetic nephropathy and type 2 diabetes mellitus. Inhibition of ACE results in decreased formation of Angiotensin II (a far more potent vasoconstrictor than Angiotensin I) and decreased inactivation of bradykinin.

Swiss-Prot Accession Number: P12821


Bibliography

ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study. (2020) Pigeyre M, Sjaarda J, Chong M, Hess S, Bosch J, Yusuf S, Gerstein H, Pare G Diabetes Care

medical_services Therapy Indications

Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response. (2008) Richardson MA, Gupta A, OBrien LA, Berg DT, Gerlitz B, Syed S, Sharma GR, Cramer MS, Heuer JG, Galbreath EJ, Grinnell BW J Pharmacol Exp Ther 325: 17-26.

medical_services Therapy Indications

Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. (2007) Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW Am J Physiol Renal Physiol 293: F245-F254.

medical_services Therapy Indications